Paul Ducheyne is Professor of Bioengineering and Professor of Orthopaedic Surgery Research at the University of Pennsylvania, Philadelphia, USA. He is the Director of its Center for Bioactive Materials and Tissue Engineering. He also is Special Guest Professor at the University of Leuven, Belgium.

Paul Ducheyne has Materials Science and Engineering degrees from the K.U. Leuven. Subsequent to postdoctoral research at the University of Florida, he started his career at the K.U. Leuven where he was one of the co-founders of the Curriculum in Bioengineering. This program is now a full M.Sc. program in the School of Engineering and Applied Sciences.

He has organized a number of symposia and meetings, such as the Fourth European Conference on Biomaterials (1983), the Engineering Foundation Conference on Bioceramics (1986) which led to the New York Academy of Sciences publication: "Bioceramics, material characteristics versus in vivo behavior", and the Sixth International Symposium on Ceramics in Medicine (1993). He has lectured around the world and serves or has served on the editorial board of 10 scientific journals in the biomaterials, bioceramics, bioengineering, tissue engineering, orthopaedics and dental fields. He has authored more than 300 papers and chapters in a variety of international journals and books, he has edited 10 books, and he has been granted more than 40 US patents with international counterparts.

Paul Ducheyne has been secretary of the European Society for Biomaterials, is Past President of the Society for Biomaterials (USA) and Past President of the International Society for Ceramics in Medicine. Among other recognitions, he is a fellow of the American Association for the Advancement of Science (AAAS), he was the first Nanyang Visiting Professor at the Nanyang Institute of Technology, Singapore and he has received the C. William Hall Award from the Society for Biomaterials.

Paul Ducheyne founded Gentis, Inc., which focuses on breakthrough concepts for spinal disorders. Previously, he founded Orthovita (NASDAQ: VITA) in 1992 and served as Chairman of its Board of Directors until 1999.  Orthovita focuses on bioceramic implant materials for orthopaedics.